1. A Systematic Review of the Efficacy and Safety of Desmopressin for Nocturia in Adults 
Mark H. Ebell, Taylor Radke, Jack Gardner 
The Journal of Urology 
Volume 192, Issue 3, Pages (September 2014)
DOI: /j.juro
Copyright © 2014 American Urological Association Education and Research, Inc. Terms and Conditions

2. Figure 1
Decrease in number of nocturnal voids per night by low vs high dose.5,7–11,13–15 Values less than zero favored treatment (fewer voids). WMD, weighted mean difference.
The Journal of Urology  , DOI: ( /j.juro )
Copyright © 2014 American Urological Association Education and Research, Inc. Terms and Conditions

3. Figure 2
Change in time to first void/duration first sleep period in minutes by low vs high dose.5,7,10,11,13–15 Values greater than zero favored treatment (longer duration). WMD, weighted mean difference.
The Journal of Urology  , DOI: ( /j.juro )
Copyright © 2014 American Urological Association Education and Research, Inc. Terms and Conditions

4. Figure 3
Overall clinical response by active run-in period.7,10,11,13–16 Values greater than 1.0 favored treatment.
The Journal of Urology  , DOI: ( /j.juro )
Copyright © 2014 American Urological Association Education and Research, Inc. Terms and Conditions

5. Figure 4
Likelihood of hyponatremia by low vs high dose.5,7–11,13–15 Values greater than 1.0 favored placebo (more hyponatremia with treatment).
The Journal of Urology  , DOI: ( /j.juro )
Copyright © 2014 American Urological Association Education and Research, Inc. Terms and Conditions